Osteoarthritis: Data Scan Powered by OE M.I.N.D. .

With over 225,000 patients across 530 trials, OrthoEvidence’s M.I.N.D. platform offers an unprecedented lens into global osteoarthritis research. OE M.I.N.D. is used to understand research and reading patterns in osteoarthritis. With data from 530 RCTs involving more than 225,000 patients, the tool shows that knee OA dominates both research activity and reader interest. Hyaluronic acid injections, physical therapy, and exercise are among the most frequently viewed treatments, with orthopaedic surgeons and physiotherapists making up the majority of readers. Most studies report pain using VAS and include a 3-month follow-up. Market analytics also show that major industry contributors—such as Pfizer, Sanofi, Novartis, and Fidia—continue to drive a large portion of OA research.